Literature DB >> 1445227

Hirulog-1 and -B2 thrombin specificity.

J I Witting, P Bourdon, J M Maraganore, J W Fenton.   

Abstract

Mesh：

Substances：

Year:  1992        PMID： 1445227      PMCID： PMC1133217          DOI： 10.1042/bj2870663

Source DB:  PubMed          Journal:  Biochem J        ISSN： 0264-6021            Impact factor:   3.857


× No keyword cloud information.
  9 in total

1.  Design and characterization of hirulogs: a novel class of bivalent peptide inhibitors of thrombin.

Authors:  J M Maraganore; P Bourdon; J Jablonski; K L Ramachandran; J W Fenton
Journal:  Biochemistry       Date:  1990-07-31       Impact factor: 3.162

2.  Domains specifying thrombin-receptor interaction.

Authors:  T K Vu; V I Wheaton; D T Hung; I Charo; S R Coughlin
Journal:  Nature       Date:  1991-10-17       Impact factor: 49.962

3.  cDNA cloning and expression of a hamster alpha-thrombin receptor coupled to Ca2+ mobilization.

Authors:  U B Rasmussen; V Vouret-Craviari; S Jallat; Y Schlesinger; G Pagès; A Pavirani; J P Lecocq; J Pouysségur; E Van Obberghen-Schilling
Journal:  FEBS Lett       Date:  1991-08-19       Impact factor: 4.124

4.  The interaction of thrombin with fibrinogen. A structural basis for its specificity.

Authors:  M T Stubbs; H Oschkinat; I Mayr; R Huber; H Angliker; S R Stone; W Bode
Journal:  Eur J Biochem       Date:  1992-05-15

5.  Anion-binding exosite of human alpha-thrombin and fibrin(ogen) recognition.

Authors:  J W Fenton; T A Olson; M P Zabinski; G D Wilner
Journal:  Biochemistry       Date:  1988-09-06       Impact factor: 3.162

6.  Proflavin binding within the fibrinopeptide groove adjacent to the catalytic site of human alpha-thrombin.

Authors:  S A Sonder; J W Fenton
Journal:  Biochemistry       Date:  1984-04-10       Impact factor: 3.162

7.  Thrombin-specific inhibition by and slow cleavage of hirulog-1.

Authors:  J I Witting; P Bourdon; D V Brezniak; J M Maraganore; J W Fenton
Journal:  Biochem J       Date:  1992-05-01       Impact factor: 3.857

8.  The structure of a complex of recombinant hirudin and human alpha-thrombin.

Authors:  T J Rydel; K G Ravichandran; A Tulinsky; W Bode; R Huber; C Roitsch; J W Fenton
Journal:  Science       Date:  1990-07-20       Impact factor: 47.728

9.  The refined 1.9 A crystal structure of human alpha-thrombin: interaction with D-Phe-Pro-Arg chloromethylketone and significance of the Tyr-Pro-Pro-Trp insertion segment.

Authors:  W Bode; I Mayr; U Baumann; R Huber; S R Stone; J Hofsteenge
Journal:  EMBO J       Date:  1989-11       Impact factor: 11.598
  9 in total
  3 in total

Review 1.  Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  David A Garcia; Trevor P Baglin; Jeffrey I Weitz; Meyer Michel Samama
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 2.  Point-of-care testing for anticoagulation monitoring in neuroendovascular procedures.

Authors:  H M Hussein; A L Georgiadis; A I Qureshi
Journal:  AJNR Am J Neuroradiol       Date:  2011-09-15       Impact factor: 3.825

3.  High-affinity alpha-thrombin binding to platelet glycoprotein Ib alpha: identification of two binding domains.

Authors:  H R Gralnick; S Williams; L P McKeown; K Hansmann; J W Fenton; H Krutzsch
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-05       Impact factor: 11.205
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.